The company’s upcoming earnings report date is not yet available.
Is CannLabs overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does CannLabs pay dividends?
CannLabs does not currently pay dividends.
What is CannLabs’s EPS estimate?
CannLabs’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does CannLabs have?
CannLabs has 942,164,730 shares outstanding.
Which hedge fund is a major shareholder of CannLabs?
Currently, no hedge funds are holding shares in CANL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
CannLabs
CannLabs, Inc. provides cannabis testing laboratory services in the United States. Its testing services include potency testing, residual solvent analysis, microbiological testing, pesticide testing, heavy metals testing, nutrient analysis, terpenes analysis, shelf-life/stability studies, gene expression testing, and genotyping/phenotyping testing. The company also offers data/analytics and consulting, as well as education services. CannLabs, Inc. was incorporated in 2010 and is based in Denver, Colorado.